Recordati Industria Chimica e Farmaceutica S.p.A.
RCDTF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $632 | $644 | $680 | $598 |
| % Growth | -1.8% | -5.3% | 13.6% | – |
| Cost of Goods Sold | $200 | $220 | $221 | $185 |
| Gross Profit | $432 | $424 | $459 | $413 |
| % Margin | 68.4% | 65.8% | 67.5% | 69.1% |
| R&D Expenses | $80 | $87 | $80 | $81 |
| G&A Expenses | $40 | $42 | $42 | $47 |
| SG&A Expenses | $171 | $187 | $181 | $184 |
| Sales & Mktg Exp. | $131 | $145 | $140 | $137 |
| Other Operating Expenses | $16 | $15 | $1 | $14 |
| Operating Expenses | $267 | $289 | $263 | $279 |
| Operating Income | $166 | $135 | $196 | $135 |
| % Margin | 26.2% | 21% | 28.8% | 22.5% |
| Other Income/Exp. Net | -$21 | -$16 | -$31 | -$29 |
| Pre-Tax Income | $145 | $119 | $165 | $105 |
| Tax Expense | $35 | $28 | $40 | $27 |
| Net Income | $110 | $91 | $125 | $78 |
| % Margin | 17.4% | 14.1% | 18.4% | 13.1% |
| EPS | 0.53 | 0.44 | 0.61 | 0.38 |
| % Growth | 20.5% | -27.9% | 60.5% | – |
| EPS Diluted | 0.53 | 0.44 | 0.6 | 0.37 |
| Weighted Avg Shares Out | 206 | 206 | 206 | 206 |
| Weighted Avg Shares Out Dil | 209 | 209 | 209 | 209 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $23 | $24 | $26 | $22 |
| Depreciation & Amortization | $51 | $51 | $51 | $45 |
| EBITDA | $219 | $195 | $242 | $173 |
| % Margin | 34.7% | 30.2% | 35.6% | 28.8% |